InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Anders Lundberg, Président du Conseil. Insider active across 1 company, notably Prostatype Genomics AB. Aggregated, 2 filings have been logged. Activity tracked since 3 October 2025. The latest transaction was filed on 12 August 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Anders Lundberg is the Chairman of the Board of Prostatype Genomics AB. As Chairman, he oversees the activities of the board and ensures the good governance of the company. Anders plays a key role in defining strategic directions and supporting the management of Prostatype Genomics AB.